Survival methods: Additional topics

Circulation

Volumn 117, Issue 22, 2008, Pages 2949-2955

  Oakes, David ^a   Peterson, Derick R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Statistics; Survival analysis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; PLACEBO;

CLINICAL TRIAL; COMPUTER PROGRAM; DRESSLER SYNDROME; FOLLOW UP; HEALTH CARE COST; HEART ARREST; HUMAN; LONG QT SYNDROME; LUNG CONGESTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME;

HUMANS; METHODS; MODELS, STATISTICAL; SURVIVAL ANALYSIS;

EID: 44649163946     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.700377     Document Type: Review

References (18)

1. Rao SR, Schoenfeld DA. Survival methods. Circulation. 2007;115:109-113.
2. Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 1998;319:385-392.
3. Hobbs JB, Peterson DR, Moss AJ, McNitt S, Zareba W, Goldenberg I, Qi M, Robinson JL, Sauer AJ, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Towbin JA, Vincent GM, Zhang L. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA. 2006;296:1249-1254.
4. Benhorin J, Moss AJ, Oakes D. Prognostic significance of nonfatal reinfarction. J Am Coll Cardiol. 1990;15:254-258.
5. Turnbull BW, Brown BW, Hu M. Survivorship analysis of heart transplant data. J Am Stat Assoc. 1974;69:74-80.
6. Mantel N, Byar DP. Evaluation of response time data involving transient states: an illustration using heart transplant data. J Am Stat Assoc. 1974;69:81-86.
7. Cox DR, Oakes D. Analysis of Survival Data. London, UK: Chapman and Hall; 1984.
8. Schoenfeld D. Sample size formula for the proportional hazards regression model. Biometrics. 1983;39:499-503.
9. Fleiss JL, Bigger JT, McDermott M, Miller JP, Moon T, Moss AJ, Oakes D, Rolnitzky LA, Therneau T. Nonfatal reinfarction is, by itself, an inappropriate end point in clinical trials in cardiology. Circulation. 1990;81:684-685.
10. Pepe MS. Inference for events with dependent risks in multiple endpoint studies. J Am Stat Assoc. 1991;86:770-778.
11. Fine JP, Gray JP. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
12. Andersen PK, Gill RD. Cox's regression model for counting processes: a large sample study. Ann Stat. 1982;10:1100-1120.
13. Prentice RL, Williams BJ, Peterson AV. On the regression analysis of multivariate failure time data. Biometrika. 1981;68:373-379.
14. Wei LJ Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modelling of marginal distributions. J Am Stat Assoc. 1989;84:1065-1073.
15. Lin DY, Feuer EJ, Etzioni R, Wax Y. Estimating medical costs from incomplete follow-up data. Biometrics. 1997;53:419-434.
16. Huang Y, Louis TA. Nonparametric estimation of the joint distribution of survival time and mark variables. Biometrika. 1998;85:785-798.
17. Zhao H, Tsiatis AA. Efficient estimation of the distribution of quality adjusted survival time. Biometrics. 1999;55:1101-1107.
18. Bang H, Tsiatis AA. Estimating medical costs with incomplete data. Biometrika. 2000;77:329-343.